Madryn Health Partners, managed by Madryn Asset Management, is a direct lending fund based in New York that focuses on the healthcare sector. Established in 2017, the fund targets investments in areas such as healthcare services and supplies, pharmaceuticals and biotechnology, as well as life sciences and oncology. Madryn Asset Management specializes in identifying unique and transformative products, technologies, and services within the healthcare industry, leveraging its extensive experience to create long-term value for its portfolio companies. The firm employs an independent research approach to uncover attractive economic opportunities that aim to deliver strong risk-adjusted returns for its investors.

The National Science Foundation (NSF), established in 1950 and located in Alexandria, Virginia, is an independent federal agency dedicated to advancing fundamental research and education across all scientific and engineering disciplines. With an annual budget of approximately $7.8 billion, the NSF operates America's Seed Fund, which allocates nearly $200 million each year to support startups and small businesses through the Small Business Innovation Research (SBIR) program. This initiative provides non-dilutive funding of up to $1.5 million to assist in research and development efforts, thereby facilitating the transformation of scientific discoveries into commercially viable products and services. By helping to de-risk technology, the NSF plays a crucial role in fostering innovation and addressing societal challenges through scientific advancements.

MassChallenge is a non-equity startup accelerator headquartered in Boston, Massachusetts, with additional locations in Israel, Mexico, Switzerland, Texas, and the UK. Founded in 2009, it focuses on fostering innovation and entrepreneurship by supporting high-potential startups across various industries globally. MassChallenge provides expert mentorship, a tailored curriculum, and access to corporate partners without taking any equity from the startups. Its programs, including specialized initiatives like MassChallenge FinTech and MassChallenge HealthTech, aim to facilitate partnerships between startups and established companies to drive innovation and growth. To date, MassChallenge has helped over 1,200 alumni raise more than $2 billion in funding and create over 65,000 jobs, demonstrating its significant impact on the global innovation ecosystem.

The EIC pilot supports top-class innovators, entrepreneurs, small companies and scientists with bright ideas and the ambition to scale up internationally. It brings together the parts of Horizon 2020 that provide funding, advice and networking opportunities for those at cutting edge of innovation.

Andreessen Horowitz is a venture capital firm established in 2009 by Marc Andreessen and Ben Horowitz, based in Menlo Park, California. The firm specializes in investing across various stages of startups, from seed to late stage, with a strong emphasis on technology sectors. Its investment focus includes software, cloud computing, enterprise solutions, and consumer Internet, as well as areas intersecting computer science and life sciences, such as digital therapeutics and computational medicine. The firm aims to fund innovative companies that contribute to American dynamism, with investments typically ranging from $50,000 to $50 million. While primarily targeting technology startups, Andreessen Horowitz has a selective approach, avoiding investments in sectors like clean energy and traditional consumer retail.

Pfizer Inc., founded in 1849 and based in the United States, is one of the world's largest pharmaceutical companies, specializing in the development and sale of prescription drugs and vaccines. With annual sales nearing $50 billion, the company focuses on improving health outcomes by providing safe, effective, and affordable medicines. Pfizer has a diverse portfolio that includes leading products such as the pneumococcal vaccine Prevnar 13, the cancer treatment Ibrance, and the cardiovascular medication Eliquis. The majority of its sales come from prescription drugs and vaccines, with nearly half of its revenue generated from international markets, particularly emerging economies. Pfizer is committed to addressing significant health care challenges through scientific innovation and aims to ensure access to essential health care services for people worldwide.

New Enterprise Associates, Inc. is a global venture capital and private equity firm based in Menlo Park, California, founded in 1977. The firm specializes in investments across various stages of company development, from seed and startup to later-stage growth and public investments. With over $19 billion in cumulative committed capital, NEA focuses on technology and healthcare sectors, particularly in areas such as consumer internet, financial technology, software, healthcare services, life sciences, and energy technology. The firm also invests in semiconductor companies and alternative energy initiatives in India. NEA has a proven track record, with more than 210 portfolio company IPOs and over 360 acquisitions. The firm's investment strategy encompasses a global perspective, targeting opportunities in North America, Asia, and South America, and typically involves investments ranging from $0.05 million to $20 million.

Casdin Capital, LLC is a New York-based investment firm established in 2012, specializing in the life sciences and healthcare sectors. The firm focuses on venture capital investments across various areas, including oncology, digital health, agtech, and broader healthcare. It operates as a Registered Investment Adviser and manages a long-short equity fund. Casdin Capital engages in both early-stage and late-stage private investments, utilizing a fundamental research approach to identify promising opportunities in its target industries. As of October 2020, the firm manages approximately $2.2 billion in assets. The founder and Chief Investment Officer, Eli Casdin, has been instrumental in shaping the firm’s investment strategy and direction.

The U.S. Department of Energy is a government agency established in 1977, located in Washington, D.C. Its primary mission is to ensure the security and prosperity of the nation by tackling energy, environmental, and nuclear challenges. The Department focuses on promoting transformative scientific and technological solutions to address these issues, thereby supporting the country's energy needs and environmental sustainability.

Novo Holdings, established in 1999 and based in Copenhagen, is the asset manager for the Novo Nordisk Foundation, overseeing its wealth and investments. The company primarily focuses on the life sciences sector, investing across various stages of company development, from early-stage ventures to established firms. Novo Holdings also manages a diversified portfolio of financial investments, including equity and fixed income securities. It is recognized as a leading life science investor globally and aims to generate long-term value to support the Foundation's grant obligations for medical and scientific research. Additionally, it plays a pivotal role in the Novo Group, maintaining a significant influence over its associated companies, including Novo Nordisk and Novozymes, while ensuring compliance with the group’s shared values and management principles. Through initiatives like Novo Seeds, the firm supports early-stage applied research in Scandinavia, further solidifying its commitment to advancing health and welfare through strategic investments.

SOSV is a global venture capital firm founded in 1995 and headquartered in Princeton, New Jersey. Specializing in seed-to-growth stage investments, SOSV operates multiple accelerator programs worldwide, including HAX for hardware, IndieBio and RebelBio for life sciences, Chinaccelerator and MOX for cross-border internet ventures, Food-X for innovative food solutions, and dlab for blockchain technology. The firm focuses on investments in revolutionary deep technologies aimed at improving human and planetary health, as well as cross-border markets, particularly in Asia. SOSV invests in approximately 150 startups annually, providing support through its resources to accelerate product development and scaling. Over its two-decade history, SOSV has established a strong reputation, consistently ranking among the top venture capital firms globally.

Temasek Holdings, established in 1974 and based in Singapore, is an investment company managing a diversified portfolio valued at approximately S$242 billion. The firm actively invests across various sectors, including telecommunications, media and technology, financial services, transportation, consumer products, real estate, life sciences, and energy. Temasek focuses on long-term investment themes such as transforming economies, growing middle-income populations, deepening comparative advantages, and supporting emerging champions. Its investment strategy encompasses a combination of liquid assets, listed and unlisted equities, and private equity opportunities, with a notable emphasis on mid-stage technology and life sciences investments through its private equity arm, Temasek Capital Management. Furthermore, Temasek aims to be the preferred investor for companies in Singapore and internationally, reflecting its commitment to global investment opportunities.

Goldman Sachs is a prominent global investment banking, securities, and investment management firm, established in 1869 and headquartered in New York City. The firm provides a range of services to corporations, financial institutions, governments, and high-net-worth individuals. Its Investment Banking segment offers advisory services for mergers and acquisitions, divestitures, and restructuring, as well as underwriting for public offerings and private placements of various securities. The Institutional Client Services segment focuses on client execution across fixed income, currencies, commodities, and equities, while also offering financing and securities lending to institutional clients. The Investing & Lending segment engages in originating long-term loans and investing in debt securities and real estate. Additionally, Goldman Sachs Asset Management serves both institutional and individual investors with comprehensive investment and advisory solutions across diverse asset classes. The firm also operates several specialized investment groups, including private equity and infrastructure funds, targeting a variety of sectors and investment strategies worldwide.

Intel Corporation is a leading global designer and manufacturer of essential technologies for cloud computing, smart devices, and connected systems. The company operates through various segments, including Data Center Group, Internet of Things Group, Mobileye, and Client Computing Group, offering a wide range of products such as microprocessors, chipsets, system-on-chip solutions, and memory products. Intel's innovations extend to high-performance computing for targeted industries, as well as technologies for computer vision and machine learning applications. The firm serves original equipment manufacturers, design manufacturers, and cloud service providers. Founded in 1968 and headquartered in Santa Clara, California, Intel also invests through Intel Capital, which has supported numerous startups in areas like artificial intelligence and cybersecurity, advancing new technologies and solutions. Intel has consistently led the semiconductor market, driven by its commitment to innovation and the development of transformative products that enhance performance, connectivity, and data utilization across various sectors, including automotive and the Internet of Things.

The Invus Group is a private equity firm based in New York, founded in 1985. It specializes in making direct and indirect investments in various stages of companies, focusing on special situations, venture capital, and growth equity. The firm manages an evergreen fund, which allows it significant flexibility in investment strategies and the types of companies it engages with, including those in consumer products, food, specialty retail, software, biotech, and medical devices. Invus emphasizes a tailored approach to each investment, recognizing the uniqueness of every business and the need for long-term commitment to foster transformation. The firm aligns its incentives with those of its partners and has a history of empowering owner-managers by reinvesting capital from a consistent group of European families. Invus operates from offices in New York, London, Paris, and Hong Kong and manages assets exceeding $4 billion.

Global Brain is a Tokyo-based venture capital firm founded in 1998, specializing in early-stage investments across various sectors, including e-commerce, software, gaming, media, IoT, education, entertainment, and fintech. The firm has expanded its investment activities to the US and Asia, targeting series A-stage technology companies. Since its inception, Global Brain has invested in approximately 30 companies, achieving seven initial public offerings and seven mergers and acquisitions. The firm supports its portfolio companies by providing not only capital but also strategic guidance, partnerships, and team-building resources to help them reach their milestones. Global Brain is particularly adept in e-commerce, operating a platform called EC-PLANET, which encompasses several group companies, including a large online sports goods store and a logistics firm offering comprehensive fulfillment services. This network, along with Global Brain's connections to established Japanese companies, facilitates market entry for US and Asian businesses into Japan.

Alexandria Venture Investments, LLC is a venture capital firm established in 1996 and headquartered in Pasadena, California. As the strategic investment arm of Alexandria Real Estate Equities, it focuses on providing capital to seed, early-stage, and growth-stage companies within the healthcare sector. The firm emphasizes investments in biopharma, diagnostics, life sciences, research tools, agrifoodtech, and agtech. Alexandria Venture Investments aims to support innovative entities developing breakthrough technologies and therapies, leveraging its extensive industry knowledge and relationships with leading investors. Its approach is characterized by a commitment to fostering innovation and entrepreneurship in the life sciences and technology sectors.

5AM Ventures is a venture capital firm founded in 2002 and headquartered in San Francisco, California, with an additional office in Boston. The firm specializes in seed and early-stage investments, primarily focusing on companies in the life sciences and healthcare sectors, including biopharmaceuticals, medical technology, and advanced research instruments. With a commitment to nurturing innovation, 5AM Ventures plays a pivotal role in supporting emerging companies that are at the forefront of scientific and technological advancements.

IMM Investment Corp. is a private equity and venture capital firm based in Seoul, South Korea, established in July 1999. The firm specializes in mezzanine investments and focuses on various strategies, including mergers and acquisitions, corporate restructuring, and management buyouts. It allocates capital across different stages of growth, with investments divided among startups, expansion, and mezzanine funding. IMM Investment primarily targets small to medium-sized companies in sectors such as information technology, healthcare, biotechnology, manufacturing, and infrastructure. The firm emphasizes active management involvement and prefers investing in companies with strong credit ratings. Additionally, it has a significant focus on industries such as IT infrastructure, wireless communications, entertainment, and digital hardware. Through its funds, IMM Investment engages in both direct investments and co-investments, aiming to support companies that require capital for growth or restructuring.

5Y Capital is a private equity and venture capital firm based in Shanghai, China, focused on seed, start-up, early venture, and growth capital investments. Founded in 2008 and previously known as Morningside Venture Capital, the firm manages approximately USD 5 billion in dual-currency funds, supported by global investors such as sovereign wealth funds, family offices, and endowments. 5Y Capital primarily invests in various sectors, including healthcare, technology, fintech, media, software, life sciences, and education, with a special emphasis on medical treatment, biotechnology, and digital health. The firm seeks opportunities in China and other emerging markets across Asia and the Pacific, aiming to support entrepreneurs in building innovative companies. 5Y Capital typically makes initial investments exceeding USD 500,000 per portfolio company and operates as a subsidiary of Morningside Group, which has been active in venture capital investments since 1992.

Ben Franklin Technology Partners of Southeastern Pennsylvania is a non-profit organization established in 1982 that serves as a vital capital provider and supporter of technology development in the region. Based in Philadelphia, it has invested over $170 million in more than 2,000 early-stage and established technology companies, fostering innovation primarily in information technology, health, and physical sciences. The organization not only provides financial support but also develops partnerships between universities and industries to accelerate the commercialization of scientific discoveries. By strengthening the local entrepreneurial ecosystem, Ben Franklin Technology Partners plays a crucial role in job creation and economic transformation in Southeastern Pennsylvania.

Morgan Stanley is a global financial services firm headquartered in New York City, specializing in investment banking, wealth management, and investment management. The firm serves a diverse clientele, including corporations, governments, and individuals, offering services such as capital raising, financial advisory, and trading in various securities. Morgan Stanley operates several private equity platforms, including Morgan Stanley Energy Partners, which invests in middle-market energy companies, and Morgan Stanley Venture Partners, focusing on late-stage investments in technology and healthcare sectors. Additionally, Morgan Stanley Infrastructure Partners targets the acquisition and transformation of undervalued infrastructure assets. The firm's investment management division encompasses a wide range of strategies, including public and private markets, and operates globally with offices in key financial centers. Through its various business lines, Morgan Stanley aims to deliver innovative solutions and strong returns to its clients while maintaining a commitment to corporate governance and responsible investing.

Massachusetts Capital Resource Company, founded in 1977 and based in Boston, Massachusetts, serves as a private investment firm focused on addressing the funding gap for growing companies. The company provides risk capital in the form of mezzanine financing, long-term debt, and equity investments, specifically targeting emerging growth and middle-market firms. Its primary sectors of interest include manufacturing, distribution, service, and technology. By offering tailored investment solutions, Massachusetts Capital complements the financing available from senior lenders and equity investors, thereby supporting the growth and acquisition needs of companies operating in Massachusetts.

SMBC Venture Capital Co., Ltd. is the private equity and venture capital arm of Sumitomo Mitsui Banking Corporation, established in 2005 and headquartered in Tokyo, Japan, with an additional office in Osaka. The firm specializes in growth capital and buyout investments, focusing on a diverse range of industries, including information technology, life sciences, services, and manufacturing. By leveraging its extensive financial services background, SMBC Venture Capital aims to support the growth and development of innovative companies in these sectors.

work with private equity and venture capital fund managers, investment advisors and business entities from around the world.

AlleyCorp, founded by Kevin Ryan in 2007, operates as both a startup studio and venture capital firm based in New York City. It focuses on founding and investing in early-stage, transformational companies, having launched notable ventures such as MongoDB, Business Insider, Gilt Groupe, Zola, Nomad Health, Workframe, and CoEdition. AlleyCorp plays an active role in the lifecycle of its companies by originating ideas, forming founding teams, and providing funding for the initial stages of development. The firm aims to support first-time founders and typically invests as the first seed investor in very early-stage companies. AlleyCorp specializes in sectors including technology, enterprise software, marketplaces, healthcare services, and robotics, with a track record of its companies collectively raising over $1 billion in funding and achieving an aggregate value exceeding $10 billion.

Samsara BioCapital LLC is a principal investment firm founded in 2016 and based in Palo Alto, California. The firm specializes in investing in biotechnology companies across the United States, with a focus on sectors such as pharmaceuticals, oncology, life sciences, and digital health. As a registered investment adviser, Samsara BioCapital aims to support innovative healthcare ventures through strategic investments.

Versant Ventures is a prominent healthcare investment firm founded in 1999 and headquartered in San Francisco, California. The firm focuses on investing in various sectors within healthcare, including biotechnology, pharmaceuticals, medical devices, and life sciences, and operates at all stages of company development. With $2.3 billion in assets under management, Versant Ventures emphasizes the discovery and development of innovative therapeutics, leveraging a team with substantial investment, operational, and scientific expertise to take a hands-on approach in building companies. The firm has a strong track record, with over 65 of its portfolio companies achieving successful acquisitions or public offerings. Versant maintains offices in Canada, the U.S., and Europe, allowing for a global investment reach.

Foresite Capital is a multi-stage investment firm specializing in healthcare and life sciences, managing $2 billion in assets. Established in 2011, the firm focuses on growth equity investments across various sectors, including pharmaceuticals, biotechnology, and healthcare technology. Foresite Capital employs a data-driven and scientific approach to its investment analysis, collaborating closely with portfolio companies through a multidisciplinary team of professionals, including scientists, engineers, analysts, and clinicians. This collaborative strategy aims to address significant unmet clinical needs by supporting promising businesses at different stages of their development. The firm places particular emphasis on companies that leverage data science and machine intelligence within the healthcare sector. Foresite Capital is headquartered in San Francisco, with an additional office in New York.

GE Equity is a division of General Electric that focuses on maximizing returns on investment capital through equity investing. It specializes in acquiring minority ownership stakes in established companies with significant growth potential. The division pursues various investment strategies, including growth capital, buy-out co-investments, secondary direct purchases, recapitalizations, and limited partner investments. Leveraging GE's extensive industry knowledge and global reach, GE Equity seeks to identify and capitalize on high-potential opportunities across multiple sectors. By combining financial acumen with operational expertise, GE Equity plays a crucial role in enhancing the overall value of General Electric's investment portfolio.

Y&R Capital, established in May 2015, is a venture capital firm based in Beijing, China, focused on high-tech incubation and service management. It was jointly founded by Zhejiang Ganzhan Investment Management Co., Ltd. and Beijing Bochuang Xingsheng Technology Co., Ltd. The firm emphasizes investment in strategic emerging industries, particularly in the fields of medical health, artificial intelligence, robotics, and intelligent manufacturing. Y&R Capital aims to identify and support innovative companies that exhibit growth potential in these sectors, aligning its investment strategy with the evolving technological landscape.

CMT Digital, established in 2015 and based in Chicago, Illinois, is the venture capital arm of Capital Markets Trading. The firm focuses on opportunistic investments in companies within the cryptocurrency and blockchain sectors, as well as digital assets. As a Registered Investment Adviser, CMT Digital aims to identify and support innovative ventures that are shaping the future of digital finance and technology.

Mitsubishi UFJ Capital Co., Ltd. is a venture capital firm based in Tokyo, Japan, established in 1974. The firm focuses on seed, development stage, and start-up investments, primarily targeting sectors such as healthcare, biotechnology, information technology, electronics, and high technology. It aims to invest in companies relevant to the Japanese market and actively engages in investment syndication for Japanese opportunities. In addition to its domestic focus, Mitsubishi UFJ Capital also makes venture investments in the United States. The firm manages several venture capital funds, including those dedicated to life sciences and technology sectors, further diversifying its investment portfolio. With additional offices in Osaka and Nagoya, Mitsubishi UFJ Capital plays a significant role in advancing innovation and growth within its targeted industries.

TMT Investments PLC, founded in 2010 and based in Saint Helier, United Kingdom, is a venture capital firm focused on investing in early-stage technology companies. The firm specializes in several key sectors, including technology, media and telecommunications, big data, cloud solutions, e-commerce, advertising technology, software as a service, and marketplaces. With a notable portfolio that includes a significant number of investments in Silicon Valley, TMT has invested in over 45 companies to date and reports net assets of approximately US$82 million. The company's primary objective is to deliver an attractive return for its shareholders, mainly through capital appreciation. TMT Investments is publicly traded on the AIM market of the London Stock Exchange.

NVP Associates, LLC is a venture capital and private equity firm based in Palo Alto, California, specializing in a diverse range of investment stages and sectors. Established in 1961, the firm focuses on seed, startup, early, mid, and late-stage investments in both listed and unlisted companies, with particular emphasis on technology, healthcare, consumer products, and financial services. NVP Associates seeks to invest between $10 million and $150 million, depending on the stage and nature of the investment, often leading or co-investing with other firms. The firm has a global investment strategy, concentrating on markets in the Asia-Pacific region, the United States, India, Israel, and China. Its portfolio spans various industries, including medical devices, information technology, enterprise software, and digital health. NVP Associates aims to support companies with strong growth potential, leveraging its extensive network and operational expertise to foster development and achieve significant returns.

NTT DOCOMO, Inc., headquartered in Tokyo, Japan, is a leading provider of wireless telecommunications services, operating as a subsidiary of Nippon Telegraph and Telephone Corporation. Founded in 1991, the company offers a wide range of mobile services, including voice and data communication, along with value-added services such as international roaming, public wireless LAN, and cloud-based enterprise solutions. Its product portfolio includes smartphones, tablets, and accessories, as well as various lifestyle services like online shopping and educational content. Additionally, NTT DOCOMO engages in venture capital through NTT Docomo Ventures, which invests in early to middle-stage companies in sectors such as fintech, telecommunications, and information technology, both in Japan and internationally. The firm aims for minority stakes in its investments and supports innovation through its accelerator program. With millions of cellular subscriptions and a significant loyalty program, NTT DOCOMO continues to play a pivotal role in shaping communication culture and technology advancements.

Roche is a global healthcare company headquartered in Basel, Switzerland, that operates in both pharmaceuticals and diagnostics. It focuses on developing innovative medicines and diagnostic tests to improve patient outcomes, particularly in oncology, virology, inflammation, and metabolic diseases. Roche's pharmaceutical division produces well-known treatments for various conditions, including cancer and autoimmune diseases, while its diagnostics division provides in-vitro diagnostic products and systems essential for disease detection and monitoring. The Roche Venture Fund, established as the company's corporate venture capital arm, invests in early-stage life science companies, particularly in biotechnology and diagnostics. The fund seeks to support innovations through investments ranging from CHF 1 million to CHF 10 million, and it has a portfolio of around 30 companies across Europe, North America, and the Pacific region. Roche is committed to advancing healthcare solutions through research, development, and strategic collaborations with other leading venture funds.

Santé Ventures is a life sciences venture capital firm based in Austin, Texas, with an additional office in Boston, Massachusetts. Established in 2006, the firm focuses on early-stage investments in companies developing innovative medical technologies and healthcare delivery models. Santé Ventures targets seed to series B funding opportunities in the med-tech, biotechnology, and health tech sectors across the United States. The firm manages $281 million in capital through two funds and operates as a Registered Investment Adviser.

Bpifrance Financement S.A. is a French financial institution that provides a wide range of financing solutions and support services for businesses at various stages of their development. Established in 1980 and based in Maisons-Alfort, France, the company offers medium to long-term loans, export insurance, real estate and equipment leasing, and working capital loans. Bpifrance also invests in startups, small and medium-sized enterprises (SMEs), and mid-cap companies through direct investments and fund management activities. Additionally, it provides consulting services for executives and training for CEOs, aiming to facilitate innovation and growth. Bpifrance was formed from the merger of several entities in July 2013, including OSEO, CDC Entreprises, and FSI, to enhance its role in supporting the financing of the French economy.

Section 32 is a California-based venture capital firm founded in 2017 by Bill Maris, who previously served as the CEO of Google Ventures. The firm focuses on early-stage investments in the life sciences, healthcare, and technology sectors across the United States. With a preference for investing between $5 million and $10 million in 25 to 30 companies, Section 32 seeks to support innovative projects that have the potential to significantly enhance the human condition. The firm operates primarily from San Diego and has raised a total of $150 million for its investment activities, targeting advancements in areas such as artificial intelligence, cybersecurity, fintech, and biotechnology. Through its strategic investments, Section 32 aims to accelerate the discovery, development, and distribution of transformative technologies.

GV Management Company, LLC, formerly known as Google Ventures, serves as the venture capital arm of Alphabet Inc., established in 2009 and headquartered in Mountain View, California, with additional offices in Boston, New York, Cambridge, and London. The firm specializes in growth capital investments across various stages, including seed, early, mid, and late stages, focusing on sectors such as life sciences, healthcare, artificial intelligence, robotics, cyber security, and agriculture. GV has invested in over 300 companies, seeking to support startups that aim to innovate and transform industries. The firm typically invests up to $50 million, with smaller amounts allocated to early-stage ventures. GV provides its portfolio companies with exceptional support by connecting them with Google's resources and talent, leveraging a team of experts in engineering, design, science, and marketing to enhance their growth potential.

Spring Lane Capital, founded in 2017 and based in Boston, Massachusetts, is a private equity investment firm focused on fostering growth in companies that operate in sectors such as energy, water, food, waste, transportation, and cleantech. The firm employs an Integrated Deployment Capital model, which allows it to partner with entrepreneurs and facilitate the development of smaller-scale projects and equipment. By emphasizing impact investments, Spring Lane Capital aims to provide solutions that address customer needs while promoting sustainability and efficiency. Its investment strategy primarily targets North American ventures in environmental services, agriculture, and related industries, positioning the firm as a key player in the drive towards innovative and environmentally responsible business practices.

East Ventures is a venture capital firm founded in 2009, with offices in Singapore, Tokyo, and Jakarta. The firm specializes in seed, early-stage, and Series A investments, focusing on technology and consumer sectors, including fintech, e-commerce, and education technology, primarily in Southeast Asia. East Ventures has supported over 170 companies across the region, with notable investments in Indonesia's unicorns such as Tokopedia and Traveloka. The firm typically invests between $0.1 million and $0.5 million and has been recognized for its consistent performance, being named the most active investor in Southeast Asia. In 2018, it launched a joint venture called EV Growth, aimed at providing growth capital to startups throughout Southeast Asia. East Ventures continues to play a significant role in nurturing the startup ecosystem in the region.

RA Capital Management, L.P. is a Boston-based venture capital firm that specializes in early and multi-stage investments in the healthcare and life sciences sectors. Founded in 2001, the firm focuses on companies developing drugs, medical devices, diagnostics, and biotechnology. RA Capital invests in a range of funding stages, from seed funding to later rounds, and is known for its willingness to invest under $1 million in initial rounds or larger sums in established companies. The firm's investment strategy emphasizes companies with promising technologies and products, particularly in areas like prevention, cost-effective diagnostics, genetic testing, and personalized medicine. The team consists of professionals with backgrounds in biology, chemistry, and medicine, enabling them to provide valuable insights into data, regulatory processes, and market demands. Additionally, RA Capital often seeks to co-invest and take board positions in its portfolio companies, enhancing their strategic growth opportunities.

Canaan VII is an early-stage venture capital fund managed by Canaan Partners, a firm founded in 1987 and based in San Francisco, California. Canaan Partners specializes in investing in innovative entrepreneurs, focusing primarily on the technology and healthcare sectors. The fund emphasizes investments in software and technology, media, and telecommunications. Over its 30 years of operation, Canaan has successfully managed over $5 billion in assets and completed more than 190 exits, demonstrating a strong track record in nurturing and scaling companies. With a team experienced in technology, infrastructure, communications, and life sciences, Canaan is committed to supporting promising ventures across a range of industries, ensuring it targets high-potential opportunities in the United States.

Andera Partners, established in 2001 and based in Paris, is a private equity firm that focuses on investing in unlisted companies across various sectors, including life sciences, sustainable energy, transportation, agribusiness, and technology. The firm manages over €2 billion in investments, primarily targeting growth-stage companies through buyouts and mezzanine debt. Andera Partners emphasizes a hands-on approach to investment, aiming to foster long-term performance by leveraging its experienced teams to anticipate economic trends. Its investment strategy includes a co-investment fund that targets investments ranging from €10 million to €20 million, with a focus on opportunities in both Europe and North America.

BlackRock is a global investment management corporation founded in 1988 and headquartered in New York City. It provides a diverse array of services, including investment advisory, risk management, and asset management across various asset classes and sectors, such as real estate, energy, and technology. The firm manages funds for a wide range of clients, including large institutions and individual investors, focusing on delivering tailored investment solutions to help secure better financial futures. BlackRock operates through its subsidiaries, including BlackRock Capital Investment Advisors, which offers investment advisory services, and BlackRock Private Equity Partners, which specializes in direct and fund investments in private equity and venture capital. With a strong emphasis on both public and private markets, BlackRock’s expertise spans multiple strategies and geographic regions, making it one of the world's largest asset managers, with trillions of dollars entrusted to its care.

TTM Technologies, headquartered in Costa Mesa, California, is a prominent global manufacturer of printed circuit boards (PCBs) and custom assemblies essential for advanced electronic products. As one of the top ten PCB manufacturers worldwide, TTM operates 15 specialized facilities, with seven located in the United States and eight in China and Hong Kong, covering approximately 4.3 million square feet of manufacturing space. The company employs around 16,000 people and emphasizes customer service and manufacturing expertise. TTM's operations are divided into two main segments: printed circuit boards, which account for the majority of revenue, and RF & S components, which include mission systems and RF microwave assemblies. The company serves various industries such as telecommunications, computing, and networking, with roughly half of its revenue generated domestically.

MUFG, headquartered in Tokyo, Japan, is a leading financial services group with a rich history spanning approximately 350 years. It operates a global network of over 2,300 offices in more than 50 countries, employing around 150,000 people. The group offers a diverse range of services, including commercial banking, trust banking, investment banking, consumer finance, asset management, and leasing. MUFG Bank, as the largest bank in Japan, provides essential banking products and services such as loans, deposits, foreign exchange, trade finance, and cash management. Additionally, the group includes subsidiaries like Mitsubishi UFJ Trust and Banking Corporation and Mitsubishi UFJ Securities Holdings, which enhance its capabilities in trust and securities services. With a focus on client-centric solutions and strong partnerships, MUFG aims to meet the financial needs of businesses, governments, and individuals while promoting sustainable growth and societal development.

Fountain Healthcare Partners is a private equity and venture capital firm based in Dublin, Ireland, with an additional office in New York. Established in 2008, the firm specializes in investments within the life sciences sector, focusing on areas such as biotechnology, biopharmaceuticals, specialty pharmaceuticals, medical devices, and diagnostics. Fountain Healthcare Partners primarily invests in early-stage and mid-stage companies, typically committing between €0.5 million and €10 million. The firm predominantly directs its capital towards opportunities in the United States and Europe, with a particular emphasis on Ireland, where it often seeks to lead or co-lead investments. The firm aims to exit its investments within three to five years, typically through an initial public offering or trade sale, and actively seeks a seat on the board of its portfolio companies.